Not to be confused with the theme park attraction Disney's Hollywood Studios. Eisner, Disney's then-chief, intended Hollywood Pictures to be a full-fledged studio, like Touchstone, but in its later ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

Please find enclosed the disclosure received from Sanofi regarding change in holding of Securities of Promoter of the Company.

Looking back at the career of the Grateful Dead bassist, starting with when the band was clean cut and called the Warlocks. Looking back at the career of the Grateful Dead bassist, starting with ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

Promoters of as many as nearly 600 companies – 597 to be precise – reduced their holdings in their companies, as per the shareholding data for the September quarter. This was significantly ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...

(AP Photo/Anjum Naveed) The Sydney Opera House sails show photos of Britain’s King Charles and Queen camilla soon after their arrival in Sydney, Australia, Friday, Oct. 18, 2024. (AP Photo/Mark Baker) ...

Agomab Ther­a­peu­tics is ben­e­fit­ing from Sanofi’s push to be­come an im­munol­o­gy pow­er­house.

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.

Sanofi reported a 25% boost in sales for its vaccines division during the third quarter, helped by earlier-than-anticipated orders of its flu shots as well as rising revenue from Beyfortus, its RSV ...